Skip to main content
. 2022 Jun 23;56(5):794–801. doi: 10.1111/apt.17092

FIGURE 2.

FIGURE 2

Time from initiation of biologics to switching treatment in children with moderate–severe disease who were eligible vs ineligible for inclusion in the original randomised controlled trials.